Posted on by Newsdesk

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

VAUGHAN, Ontario–(BUSINESS WIRE)–
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Zenlens CHROMA HOA scleral contact lenses. Designed to correct advanced higher-order aberrations (HOA), this custom, wavefront-guided scleral lens technology delivers enhanced vision and improves clarity by reducing symptoms such as halos and glare.

“Zenlens CHROMA HOA is a high-quality, customizable lens that fills a critical gap in scleral lens vision correction, especially for patients with complex corneal irregularities,” said Yang Yang, president, Global Vision Care, Bausch + Lomb. “Eye care professionals in the U.S. now have a new solution for patients that previously had limited options to improve vision quality.”

HOA correction starts with a secure lens fit1,which can be achieved through proprietary Zenlens technologies, including SmartCurve™ and Bi-Elevation™. Once lens stability is secured, custom HOA correction is applied to the lens to effectively reduce higher-order aberrations and enhance vision by minimizing blurring and distortion.

“For years, I’ve had patients who struggle with visual distortions caused by higher-order aberrations, and there was little I could do beyond basic correction,” said Jason Jedlicka, OD, chief of cornea and contact lens service and clinical professor, Indiana University School of Optometry. “With Zenlens CHROMA HOA, I can offer a level of precision that wasn’t previously possible, and my patients can experience sharper vision and improved clarity, which has a significant impact on their quality of life.”

Bausch + Lomb is collaborating with Advance Medical and OVITZ® to help eye care professionals integrate Zenlens CHROMA HOA into their practices. Advance Medical’s FocalPoints® software platform – a leading platform for specialty lens manufacturing – enables seamless and precise production of the Zenlens CHROMA HOA design. OVITZ, the first company to develop an aberrometry system specifically for HOA correction, is providing its latest device, the xwave aberrometer.

For more information on Zenlens CHROMA HOA, visit www.bauschsvp.com/lenses/zenlens.

Important Safety Information for Gas Permeable and Customized Soft Contact Lenses

WARNINGS:

Patients should be advised of the following warnings pertaining to contact lens wear:

  • Problems with contact lenses and lens care products could result in serious injury to the eye. It is essential that patients follow their eyecare practitioner’s directions and all labeling instructions for proper use of lenses and lens care products, including the lens case. Eye problems, including corneal ulcers, can develop rapidly and lead to loss of vision.
  • Daily wear lenses are not indicated for overnight wear, and patients should be instructed not to wear lenses while sleeping. Clinical studies have shown that the risk of serious adverse reactions is increased when daily wear lenses are worn overnight.
  • Studies have shown that contact lens wearers who are smokers have a higher incidence of adverse reactions than nonsmokers.
  • If a patient experiences eye discomfort, excessive tearing, vision changes, or redness of the eye, the patient should be instructed to immediately remove lenses and promptly contact his or her eyecare practitioner.

CONTRAINDICATIONS:

Do not use when any of the following conditions exist:

  • Acute or subacute inflammation or infection of the anterior chamber of the eye.
  • Any eye disease, injury or abnormality, other than keratoconus, PMD, that affects the cornea, conjunctiva or eyelids
  • Severe insufficiency of lacrimal secretion (dry eye)
  • Corneal hypoesthesia (reduced sensitivity), if not aphakic
  • Any systemic disease that may affect the eye or be exaggerated by wearing contact lenses
  • Allergic reactions of ocular surfaces or adnexa that may be induced or exaggerated by wearing contact lenses or using contact lens solutions
  • Allergy to any ingredient in a solution which is to be used to care for contact lenses
  • Any active corneal infection (bacterial, fungal or viral)
  • Red or irritated eyes

ADVERSE EFFECTS:

The following problems may occur with the use of contact lenses:

  • Eyes stinging, burning, itching, irritation or other eye pain
  • Comfort is less than when the lens was first placed on the eye
  • Feeling of something in the eye such as a foreign body, scratched area
  • Excessive watering (tearing) of the eye
  • Unusual eye secretions
  • Redness of the eyes
  • Reduced sharpness of vision (poor visual acuity)
  • Blurred vision, rainbows, or halos around objects
  • Sensitivity to light (photophobia)
  • Dry eyes

About HOAs

HOAs are complex irregularities in the eye’s lens or cornea that can significantly impact visual clarity. They result from factors such as irregularities in the corneal shape, scarring, previous eye surgeries, large pupils or certain medical conditions affecting the eye, such as keratoconus or other corneal dystrophies. They can also be induced by the aging process or from changes in the eye’s internal structures. Patients who have HOAs can experience symptoms such as blurred vision, halos, glare and difficulty seeing in low light conditions such as driving at night.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

Reference

  1. Shah P, Gidosh N. Awesome vision after aberration control: the future of scleral lens optics. Poster presented at: The Global Specialty Lens Symposium; January 17-20, 2024; Las Vegas, NV.

FocalPoints is a trademark of Advanced Medical.

All other product/brand names are trademarks of the respective owners.

© 2025 Bausch + Lomb.

ALZN.0026.USA.25

Media:

Kristy Marks

[email protected]

(908) 927-0683

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Medical Devices Health Technology Optical Software

MEDIA:

Logo
Logo